Patents by Inventor Andre Aube

Andre Aube has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF POLYCHITOSAMINE AND HMG-COA REDUCTASE INHIBITOR FOR HYPERLIPIDEMIA
    Publication number: 20120258932
    Abstract: Combinations of therapeutic compounds for prophylaxis or treatment of hyperlipidemia and hyperlipidemia related disorders, such as hypercholesterolemia and the resultant atherosclerosis in a mammal. The combinations are useful for reducing serum cholesterol, and/or cholesteryl ester, triglycerides, phospholipids and fatty acids in a mammal. The methods of the preferred embodiments comprise administering to a mammal a first amount of polychitosamine and a second amount of an HMG-CoA reductase inhibitor (statin).
    Type: Application
    Filed: February 10, 2012
    Publication date: October 11, 2012
    Inventors: ANDRÉ AUBÉ, Jean-Guy Lehoux, Ryszard Brzezinski, Gilles Dupuis
  • COMBINATION OF POLYCHITOSAMINE AND HMG-COA REDUCTASE INHIBITOR FOR HYPERLIPIDEMIA
    Publication number: 20110028429
    Abstract: Combinations of therapeutic compounds for prophylaxis or treatment of hyperlipidemia and hyperlipidemia related disorders, such as hypercholesterolemia and the resultant atherosclerosis in a mammal. The combinations are useful for reducing serum cholesterol, and/or cholesteryl ester, triglycerides, phospholipids and fatty acids in a mammal. The methods of the preferred embodiments comprise administering to a mammal a first amount of polychitosamine and a second amount of an HMG-CoA reductase inhibitor (statin).
    Type: Application
    Filed: March 30, 2010
    Publication date: February 3, 2011
    Inventors: André Aubé, Jean-Guy Lehoux, Ryszard Brzezinski, Gilles Dupuis
  • Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia
    Publication number: 20090197830
    Abstract: Combinations of therapeutic compounds for prophylaxis or treatment of hyperlipidemia and hyperlipidemia related disorders, such as hypercholesterolemia and the resultant atherosclerosis in a mammal. The combinations are useful for reducing serum cholesterol, and/or cholesteryl ester, triglycerides, phospholipids and fatty acids in a mammal. The methods of the preferred embodiments comprise administering to a mammal a first amount of polychitosamine and a second amount of an HMG-CoA reductase inhibitor (statin).
    Type: Application
    Filed: September 14, 2005
    Publication date: August 6, 2009
    Inventor: Andre Aube
  • CHITIN DERIVATIVES FOR HYPERLIPIDEMIA
    Publication number: 20090054373
    Abstract: The preferred embodiments relate to chitin derivatives for prevention or treatment of hyperlipidemia, such as hypercholesterolemia and the resultant atherosclerosis in a mammal. The preferred embodiments are useful for reducing serum cholesterol, and/or cholesteryl ester, triglycerides, phospholipids and fatty acids in a mammal.
    Type: Application
    Filed: July 21, 2006
    Publication date: February 26, 2009
    Applicant: DNP Canada Inc.
    Inventors: Andre Aube, Ryszard Brzezinski, Gilles Dupuis, Jean-Guy Lehoux
  • Combination of Polychitosamine and Fibrate for the Prevention and Treatment of Hyperlipidemia
    Publication number: 20080293671
    Abstract: The present invention relates to pharmaceutical compositions comprising a fibrate (e.g. ciprofibrate, gemfibrozil, benzafibrate, and fenofibrate) and a polychitosamine (e.g. chitosan) having molecular weights of less than 650 Kda and degrees of deacetylation of from 70% to 100%. Uses of said compositions for the treatment of hyperlipidemia and associated conditions (e.g. hypercholesterolemia, atherosclerosis, coronary heart disease and cardiovascular disease) or as functional foods are also disclosed.
    Type: Application
    Filed: September 28, 2006
    Publication date: November 27, 2008
    Applicant: DNP Canada, Inc.
    Inventors: Andre Aube, Ryszard Brzezinski, Gilles Dupuis, Jean-Guy Lehoux
  • Chitin derivatives for hyperlipidemia
    Publication number: 20060058261
    Abstract: The preferred embodiments relate to chitin derivatives for prevention or treatment of hyperlipidemia, such as hypercholesterolemia and the resultant atherosclerosis in a mammal. The preferred embodiments are useful for reducing serum cholesterol, and/or cholesteryl ester, triglycerides, phospholipids and fatty acids in a mammal.
    Type: Application
    Filed: September 1, 2005
    Publication date: March 16, 2006
    Inventor: Andre Aube